Engineering and Technology - Research article Open Access Logo

In vitro and in vivo evaluation of sustained release ketoprofen-loaded nanoparticles

Tuyen Thi Phuong Dao 1, *
Nhan Ngoc Thanh Le 2
Anh Tuan Nguyen 1
Khai Tan Tran 1
Dam Duy Le 1
Chien Mau Dang 1
Chi Tai Nguyen 2
  1. Laboratory for Nanotechnology, VNU HCM
  2. University of Medicine and Pharmacy at HCM
Correspondence to: Tuyen Thi Phuong Dao, Laboratory for Nanotechnology, VNU HCM. Email: pvphuc@vnuhcm.edu.vn.
Volume & Issue: Vol. 16 No. 1 (2013) | Page No.: 15-25 | DOI: 10.32508/stdj.v16i1.1415
Published: 2013-03-31

Online metrics


Statistics from the website

  • Abstract Views: 0
  • Galley Views: 0

Statistics from Dimensions

Copyright The Author(s) 2023. This article is published with open access by Vietnam National University, Ho Chi Minh city, Vietnam. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

The purpose of this study is to i) fabricate a biodegradable nanoparticle formulation of Ketoprofen, ii) evaluate its characteristics, iii) investigate its in vitro dissolution and in vivo pharmaceutical property. The nanoparticle formulation was prepared by spray drying method using Eudragit L100 as the matrix polymer. Size and morphology of drug-loaded nanoparticles were characterized with the electron microscopes (TEM, SEM). These successfully prepared nanoparticles by spray drying method are spherical in shape and quite homologous with diameter size of 100 – 200 nm. The in vitro dissolution studies were conducted at pH 1.2 and 7.4. The results indicated that there is a significant increase in Keto concentration at pH 7.4 compared to pH 1.2. For the in vivo assessment, our Keto-loaded nanoparticles and referential Profenid were administered by oral gavages to rabbits. The results implied that Keto-loadednanoparticles remarkably increased AUC compared to Profenid.

Comments